Chronic Eosinophilic Leukemia
What is Chronic Eosinophilic Leukemia?
Chronic eosinophilic leukemia is a rare blood cancer that affects your white blood cells. It happens when eosinophils, a type of white blood cell that normally fights infections and allergies, grow out of control. These cells multiply too quickly and do not work properly.
This condition is part of a group of blood disorders called myeloproliferative neoplasms. Your bone marrow makes too many abnormal eosinophils that crowd out healthy blood cells. Over time, these abnormal cells can damage your organs including your heart, lungs, skin, and nervous system.
Chronic eosinophilic leukemia is different from chronic myeloid leukemia because it does not have the BCR-ABL gene mutation. Doctors diagnose it when blast cells make up more than 20% of bone marrow cells and eosinophils show abnormal features under a microscope. Early detection through blood testing helps manage this condition before serious complications develop.
Symptoms
Symptoms of chronic eosinophilic leukemia vary depending on which organs are affected by excess eosinophils.
- Fatigue and weakness that does not improve with rest
- Fever and night sweats without infection
- Weight loss without trying
- Cough and shortness of breath
- Skin rashes, itching, or unusual lesions
- Muscle pain and joint aches
- Swelling in your abdomen from enlarged spleen or liver
- Heart problems including chest pain or irregular heartbeat
- Numbness or tingling in hands and feet
- Confusion or memory problems
Some people have no symptoms in the early stages. Others experience severe organ damage before diagnosis. Regular blood testing can detect abnormal eosinophil levels before you feel sick.
Concerned about Chronic Eosinophilic Leukemia? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Chronic eosinophilic leukemia happens when genetic changes in bone marrow cells cause eosinophils to multiply uncontrollably. In many cases, doctors find specific gene mutations or chromosomal abnormalities that drive this growth. Some people have mutations in genes like PDGFRA, PDGFRB, or FGFR1 that can be targeted with treatment. Others have no identifiable genetic cause.
Risk factors for this condition are not well understood because it is so rare. It can affect adults at any age but is most common in people between 40 and 60 years old. Men develop it slightly more often than women. Unlike some cancers, chronic eosinophilic leukemia is not linked to lifestyle factors like smoking or diet. There is no evidence that it runs in families or can be prevented through lifestyle changes.
How it's diagnosed
Doctors diagnose chronic eosinophilic leukemia through blood tests and bone marrow examination. A complete blood count with differential shows very high eosinophil levels, often above 1,500 cells per microliter. Rite Aid offers eosinophil testing as part of our flagship panel to help detect abnormal white blood cell counts early. If your eosinophils are elevated, your doctor will order additional tests to find the cause.
Bone marrow biopsy confirms the diagnosis by showing more than 20% blast cells and abnormal eosinophils with unusual shapes or features. Genetic testing looks for specific mutations that distinguish chronic eosinophilic leukemia from other blood disorders. Your doctor will also test for the BCR-ABL gene to rule out chronic myeloid leukemia. Imaging tests like chest X-rays and echocardiograms check for organ damage caused by eosinophil infiltration.
Treatment options
Treatment for chronic eosinophilic leukemia depends on your genetic test results and symptoms.
- Targeted therapy drugs like imatinib work for people with PDGFRA or PDGFRB gene mutations and can lead to long-term remission
- Chemotherapy medications reduce eosinophil counts when targeted therapy is not an option
- Corticosteroids like prednisone temporarily lower eosinophil levels and reduce inflammation
- Bone marrow or stem cell transplant may be considered for younger patients when other treatments fail
- Regular blood tests monitor eosinophil counts and check how well treatment is working
- Medications to protect organs damaged by eosinophils, including heart and lung treatments
- Supportive care including blood transfusions if healthy blood cell counts drop too low
Your doctor will create a treatment plan based on your specific genetic mutations and overall health. Most people need ongoing monitoring even after treatment starts. Regular follow-up appointments and blood tests help catch any changes early.
Concerned about Chronic Eosinophilic Leukemia? Get tested at Rite Aid.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
Chronic eosinophilic leukemia is a cancer where abnormal eosinophils grow uncontrollably in your bone marrow. A high eosinophil count can have many causes including allergies, parasites, or autoimmune diseases. Leukemia is diagnosed when bone marrow shows more than 20% blast cells and genetic abnormalities. Your doctor will do additional testing to find the exact cause of elevated eosinophils.
Some people with specific genetic mutations achieve long-term remission with targeted therapy drugs like imatinib. Others require ongoing treatment to control the disease. Bone marrow transplant offers a potential cure for some patients but carries significant risks. Your prognosis depends on your genetic profile, how early the disease is caught, and how well you respond to treatment.
Chronic eosinophilic leukemia is very rare, affecting fewer than 1 in 100,000 people each year. It accounts for a small fraction of all blood cancers. Because it is so uncommon, many doctors have limited experience diagnosing and treating it. Treatment at a cancer center with blood disorder specialists is often recommended.
Chronic eosinophilic leukemia typically causes eosinophil counts above 1,500 cells per microliter. Normal eosinophil levels are usually below 500 cells per microliter. However, high eosinophils alone do not confirm leukemia. Your doctor needs bone marrow biopsy and genetic testing to make the diagnosis and rule out other causes of eosinophilia.
Excess eosinophils release toxic proteins and chemicals that damage tissues when they infiltrate organs. The heart is commonly affected, leading to inflammation, scarring, and heart failure. Lungs can develop scarring and breathing problems. Skin, nervous system, and digestive tract can also be damaged by eosinophil infiltration.
Most people without symptoms do not need screening for this rare cancer. However, regular blood testing can catch elevated eosinophils before you feel sick. Rite Aid offers eosinophil testing as part of our routine health panel. If your levels are high, your doctor can investigate the cause early and start treatment if needed.
Common mutations include PDGFRA, PDGFRB, and FGFR1 gene rearrangements. These mutations cause cells to grow uncontrollably. Finding these mutations is important because targeted drugs can block their effects. Your doctor will test for these and other genetic changes once chronic eosinophilic leukemia is suspected.
Most people need blood tests every 1 to 3 months during treatment to monitor eosinophil counts and check treatment response. Once in remission, testing may spread to every 3 to 6 months. Your doctor will determine your schedule based on how stable your condition is. Regular monitoring helps catch any disease progression early.
Lifestyle changes cannot treat or cure this cancer, but they support your overall health during treatment. Eating nutritious foods helps maintain strength. Getting enough rest supports your immune system. Avoiding infections is important because treatment can lower your healthy white blood cell counts. Talk to your doctor about safe activities during treatment.
Life expectancy varies widely depending on genetic mutations, treatment response, and organ damage at diagnosis. People with PDGFRA mutations who respond to imatinib can have near-normal life expectancy. Others may progress more quickly without effective treatment options. Early detection and specialized care improve outcomes significantly.